Cequent Pharmaceuticals Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $46M
Latest Deal Amount

Cequent Pharmaceuticals General Information

Description

Developer of RNAi based therapies. The company focuses on biopharmaceutical products based on RNA interference (RNAi) to prevent and treat a range of human diseases, such as inflammatory diseases and cancer.

Contact Information

Formerly Known As
Cequent
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • One Kendall Square
  • Building 700, 1st Floor
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cequent Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Apr-2010 $46M 000.00 0000 Completed Product Development
2. Later Stage VC (Series A1) 30-Oct-2009 00.000 000.00 000.00 Completed Product Development
1. Early Stage VC (Series A) 15-Aug-2008 $14.8M $14.8M 000.00 Completed Product Development
To view Cequent Pharmaceuticals’s complete valuation and funding history, request access »

Cequent Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00 00 00 00 00.00 0.000
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view Cequent Pharmaceuticals’s complete cap table history, request access »

Cequent Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ampersand Capital Partners Growth/Expansion Minority 000 0000 000000 0
NMT Capital PE/Buyout Minority 000 0000 000000 0
New England Partners PE/Buyout Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
To view Cequent Pharmaceuticals’s complete investors history, request access »